Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR.
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
BMJ. 2000 Aug 12;321(7258):412-9.

Amarenco P, Boqouslavssky J, Callahan AS et al.
Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study.
Cerebrovasc Dis. 2003;16(4):389-95.

Bamford J, Dennis M, Sandercock P, Burn J, Warlow C.
The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project.
J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):824-9.

Bonaa KH, Njolstad I, Ueland PM et al.
Homocysteine lowering and cardiovascular events after acute myocardial infarction.
N Engl J Med. 2006 Apr 13;354(15):1578-88. Epub 2006 Mar 12.

Chalmers J.
Global impact of stroke.
Heart Dis. 2000 Mar-Apr;2(2):S13-7.

Goldstein LB, Adams R, Becker K, et al.
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
Circulation. 2001 Jan 2;103(1):163-82.

Hankey GJ, Slattery JM, Warlow CP.
Can the long term outcome of individual patients with transient ischaemic attacks be predicted accurately?
J Neurol Neurosurg Psychiatry. 1993 Jul;56(7):752-9.

Hansson L, Hedner T, Dahlöf.
Prospective Randomized Open Blinded End-point (PROBE) StudyA novel design for intervention trials.
Blood Press 1992;1:113-119.

Heart Outcomes Prevention Evaluation Study Investigators.
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy.
Lancet. 2000 Jan 22;355(9200):253-9.

Heart Protection Study Collaborative Group.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Lancet. 2002 Jul 6;360(9326):7-22.

Lonn E, Yusuf S, Arnbold MJ et al.
Homocysteine lowering with folic acid and B vitamins in vascular disease.
N Engl J Med. 2006 Apr 13;354(15):1567-77.
Epub 2006 Mar 12.

Neal B, MacMahon S.
PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee
J Hypertens. 1995 Dec;13(12 Pt 2):1869-73.
Stroke Trials Directory: PROGRESS

Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C.
Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group.
BMJ. 1996 Jul 20;313(7050):147.

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet. 2001 Sep 29;358(9287):1033-41.
Stroke Trials Directory: PROGRESS

Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.
Stroke. 2003 Jul;34(7):1699-703.
Stroke Trials Directory: ACCESS

Schrader J, Luders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group.
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
Stroke. 2005 Jun;36(6):1218-26.
Stroke Trials Directory: MOSES

Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet. 2003 Apr 5;361(9364):1149-58.

UK Prospective Diabetes Study (UKPDS) Group.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
Lancet. 1998 Sep 12;352(9131):837-53.

UK Prospective Diabetes Study Group.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.
BMJ. 1998 Sep 12;317(7160):703-13.

Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M.
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
JAMA. 2004 Feb 4;291(5):565-75.
Stroke Trials Directory: VISP